Laser In-situ Keratomileusis With Crosslinking Compared to Conventional LASIK in Patients With High Myopia

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 24, 2014

Primary Completion Date

July 3, 2018

Study Completion Date

July 3, 2018

Conditions
MyopiaMyopic AstigmatismCrosslinkingCorneal EctasiaMyopic Regression
Interventions
PROCEDURE

LasikXtra

By randomized selection, one eye was treated with the LASIK Xtra procedure that consists of fs-LASIK treatment combined with intraoperative accelerated continuous UV-riboflavin crosslinking. After laser ablation, the corneal bed under the flap was coated with riboflavin, rinsed with saline solution, and after 90 seconds the corneal flap was repositioned. The eye was irradiated at 30 mW/cm2 for 90 seconds with continuous UVA.

PROCEDURE

LASIK

Femtosecond-assisted preparation of a corneal flap and subsequently excimer-laser ablation of corneal stroma. Repositioning of the corneal flap and installation of a therapeutic contact lens.

Trial Locations (1)

60590

Department of ophthalmology University clinic Frankfurt, Frankfurt am Main

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Glaukos Corporation

INDUSTRY

lead

University Clinic Frankfurt

OTHER

NCT03913338 - Laser In-situ Keratomileusis With Crosslinking Compared to Conventional LASIK in Patients With High Myopia | Biotech Hunter | Biotech Hunter